Unknown

Dataset Information

0

Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.


ABSTRACT: Among gliomas, primary tumors originating from glial cells, glioblastoma (GBM) identified as WHO grade IV glioma, is the most common and aggressive malignant brain tumor. We have previously shown that the Escherichia coli protein toxin cytotoxic necrotizing factor 1 (CNF1) is remarkably effective as an anti-neoplastic agent in a mouse model of glioma, reducing the tumor volume, increasing survival, and maintaining the functional properties of peritumoral neurons. However, being unable to cross the blood-brain barrier (BBB), CNF1 requires injection directly into the brain, which is a very invasive administration route. Thus, to overcome this pitfall, we designed a CNF1 variant characterized by the presence of an N-terminal BBB-crossing tag. The variant was produced and we verified whether its activity was comparable to that of wild-type CNF1 in GBM cells. We investigated the signaling pathways engaged in the cell response to CNF1 variants to provide preliminary data to the subsequent studies in experimental animals. CNF1 may represent a novel avenue for GBM therapy, particularly because, besides blocking tumor growth, it also preserves the healthy surrounding tissue, maintaining its architecture and functionality. This renders CNF1 the most interesting candidate for the treatment of brain tumors, among other potentially effective bacterial toxins.

SUBMITTER: Colarusso A 

PROVIDER: S-EPMC7290510 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.

Colarusso Andrea A   Maroccia Zaira Z   Parrilli Ermenegilda E   Germinario Elena Angela Pia EAP   Fortuna Andrea A   Loizzo Stefano S   Ricceri Laura L   Tutino Maria Luisa ML   Fiorentini Carla C   Fabbri Alessia A  

Toxins 20200504 5


Among gliomas, primary tumors originating from glial cells, glioblastoma (GBM) identified as WHO grade IV glioma, is the most common and aggressive malignant brain tumor. We have previously shown that the <i>Escherichia coli</i> protein toxin cytotoxic necrotizing factor 1 (CNF1) is remarkably effective as an anti-neoplastic agent in a mouse model of glioma, reducing the tumor volume, increasing survival, and maintaining the functional properties of peritumoral neurons. However, being unable to  ...[more]

Similar Datasets

| S-EPMC6441370 | biostudies-literature
| S-EPMC10427669 | biostudies-literature
| S-EPMC4864261 | biostudies-literature
| S-EPMC8888627 | biostudies-literature
| S-EPMC10519979 | biostudies-literature
| S-EPMC6405130 | biostudies-literature
2023-11-03 | GSE246708 | GEO
| S-EPMC6238258 | biostudies-literature
| S-EPMC7141851 | biostudies-literature
| S-EPMC10155653 | biostudies-literature